These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31881123)

  • 21. Clinical value of preoperative serum tumor markers CEA, CA19-9, CA125, and CA15-3 in surgically treated urachal cancer.
    Stokkel LE; van Rossum HH; van de Kamp MW; Boellaard TN; Bekers EM; Kok NFM; van Rhijn BWG; Mertens LS
    Urol Oncol; 2023 Jul; 41(7):326.e17-326.e24. PubMed ID: 36813613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C.
    Assmar M; Yeganeh S; Mansourghanaei F; Amirmozafari N
    Iran J Public Health; 2016 Dec; 45(12):1645-1651. PubMed ID: 28053931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
    Yu Y; Qian J; Shen L; Ji W; Lu S
    Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis.
    Wen Z; Huang Y; Ling Z; Chen J; Wei X; Su R; Tang Z; Wen Z; Deng Y; Hu Z
    Dis Markers; 2020; 2020():4716793. PubMed ID: 33488842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conventional Tumor Markers in Cerebralspinal Fluid in Patients with Elevated Serum Tumor Markers and without Central Nervous System Malignant Diseases.
    Liu ZJ; Shi Q; Lu B; Zhang Z; Tian CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):539-542. PubMed ID: 27825410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S; Shen L; Qian N; Chen K
    Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma.
    Feng LX; Wang J; Yu Z; Song SA; Zhai WX; Dong SH; Yu HS; Zhang Y
    Clin Transl Oncol; 2019 Aug; 21(8):1005-1013. PubMed ID: 30637712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?
    Szekanecz E; Sándor Z; Antal-Szalmás P; Soós L; Lakos G; Besenyei T; Szentpétery A; Simkovics E; Szántó J; Kiss E; Koch AE; Szekanecz Z
    Ann N Y Acad Sci; 2007 Jun; 1108():359-71. PubMed ID: 17893999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
    Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
    Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
    Zhu FL; Ling AS; Wei Q; Ma J; Lu G
    Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma.
    Chen HJ; Tu CY; Huang KY; Chien CR; Hsia TC
    PLoS One; 2020; 15(12):e0240736. PubMed ID: 33306683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
    Brown RW; Campagna LB; Dunn JK; Cagle PT
    Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer.
    Zhao W; Li X; Wang W; Chen B; Wang L; Zhang N; Wang Z; Yang Q
    Dis Markers; 2021; 2021():5529106. PubMed ID: 34621407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer.
    Liu F; Du F; Chen X
    World J Surg Oncol; 2014 Nov; 12():333. PubMed ID: 25381564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
    Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
    Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion.
    Gu Y; Zhai K; Shi HZ
    Chin Med J (Engl); 2016 Feb; 129(3):253-8. PubMed ID: 26831224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
    Ng WW; Tong KJ; Tam TN; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
    Xu C; Qian L; Yu L; Zhang X; Wang Q
    Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.